Showing results (181-190 of 1,012) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|June 28, 2023
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic AlterationsKazunori Aoki, Yukari Nishito, Noriko Motoi, et al.Cancer Research Communications|September 27, 2023
DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP InhibitorsHelena Folly-Kossi, Joshua D Graves, Lidija A Wilhelms Garan, et al.Cancer Research Communications|September 14, 2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersBoris Guyot, Flora Clément, Youenn Drouet, et al.Cancer Research Communications|September 7, 2023
Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven InflammationValerie P O'Brien, Yuqi Kang, Meera K Shenoy, et al.Cancer Research Communications|September 29, 2023
Marijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with CancerTheodore M Brasky, Alison M Newton, Sara Conroy, et al.Cancer Research Communications|October 3, 2023
Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening TestA Mark Fendrick, David Lieberman, Jing Voon Chen, et al.Cancer Research Communications|March 11, 2026
Constitutive EGFR activation induced by PTPRR downregulation confers resistance to KRAS inhibitorsHiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi, et al.Cancer Research Communications|March 6, 2026
A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation resultsBarak Talmor, Stefano Marastoni, Brandon Lau, et al.Cancer Research Communications|February 21, 2026
Nanobody-Engineered CLL-1 CAR-T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor ToxicityChakrapani Tripathi, Sergey Zolov, John Nguyen, et al.Cancer Research Communications|March 30, 2026
Enhancement of CD117-targeted bispecific T-cell engagement by CD33-targeted bispecific T-cell co-stimulation in acute myeloid leukemiaMara Hofstetter, Laura Volta, Christian Koch, et al.Pageof 102